Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-045322
Filing Date
2013-09-23
Accepted
2013-09-23 20:33:29
Documents
1
Period of Report
2013-09-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7148
  Complete submission text file 0001209191-13-045322.txt   9672
Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address
TANG KEVIN C (Reporting) CIK: 0001178579 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 131110984

Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL PARTNERS LP (Reporting) CIK: 0001191935 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 131110985

Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL MANAGEMENT LLC (Reporting) CIK: 0001232621 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 131110983

Mailing Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9363 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 (514) 337-3333
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations